AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18451770 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrée with reduced energy density (1.2 kcal/g)
Number of subjects: 61
Study 18451770 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrée with increased proportion of vegetables
Number of subjects: 61
Study 18451770 — intervention group
Group type: COMPARATOR
Intervention: Entrée with decreased portion size (300 g)
Number of subjects: 61
Study 18451770 — intervention group
Group type: COMPARATOR
Intervention: Entrée with standard energy density (1.6 kcal/g)
Number of subjects: 61
Study 16250284 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser tonsillectomy
Number of subjects: 60
Study 16250284 — intervention group
Group type: COMPARATOR
Intervention: Conventional dissection technique
Number of subjects: 60
Study 12408202 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Lifestyle Trial
Number of subjects: 279
Study 12408202 — intervention group
Group type: COMPARATOR
Intervention: Peer-led support group
Number of subjects: 279
Study 12408202 — intervention group
Group type: COMPARATOR
Intervention: Personalized multilevel community resources maintenance condition
Number of subjects: 279
Study 10406068 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 0
Study 10406068 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 0
Study 7482214 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitized imaging systems
Number of subjects: 0
Study 7482214 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitized single-chip cameras
Number of subjects: 0
Study 2269803 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanethidine
Number of subjects: 21
Study 2269803 — intervention group
Group type: EXPERIMENTAL
Intervention: Reserpine
Number of subjects: 21
Study 2269803 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 21
Study 6902639 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole-trimethoprim
Number of subjects: 27
Study 6902639 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 27
Study 31031186 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 kV tube voltage, 350 mgI/kg contrast dose, ASIR‐V from 40% to 100%
Number of subjects: 60
Study 31031186 — intervention group
Group type: COMPARATOR
Intervention: 120 kV tube voltage, 600 mgI/kg contrast dose, 40% ASIR
Number of subjects: 60
Study 30592997 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (2 mg)
Number of subjects: 35
Study 30592997 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 35
Study 27744624 — intervention group
Group type: EXPERIMENTAL
Intervention: SYM-1219 (2 g secnidazole) with EE2 (0.035 mg) and NET (1 mg) tablets
Number of subjects: 54
Study 27744624 — intervention group
Group type: EXPERIMENTAL
Intervention: SYM-1219 (2 g secnidazole) followed by EE2 (0.035 mg) and NET (1 mg) tablets 1 day later
Number of subjects: 54
Study 27744624 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of SYM-1219 with EE2/NET
Number of subjects: 54
Study 25770973 — intervention group
Group type: EXPERIMENTAL
Intervention: Wraparound LAD
Number of subjects: 452
Study 25770973 — intervention group
Group type: COMPARATOR
Intervention: Non-wraparound LAD
Number of subjects: 452
Study 25395378 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/day orally
Number of subjects: 79
Study 25395378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 25395378 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 79
Study 22524072 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to a pictorial story about going to the dentist
Number of subjects: 80
Study 22524072 — intervention group
Group type: COMPARATOR
Intervention: Listening to a pictorial story about going to a barbershop
Number of subjects: 80
Study 19551696 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg daily for 12 weeks
Number of subjects: 41
Study 19551696 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2-week single-blind period)
Number of subjects: 41
Study 17566844 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel 70 mg/m(2) and carboplatin AUC 5
Number of subjects: 39
Study 17566844 — intervention group
Group type: COMPARATOR
Intervention: paclitaxel 175 mg/m(2) and carboplatin AUC 5
Number of subjects: 39
Study 15137919 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (cycling for 45 min at 62 % maximal heart rate)
Number of subjects: 11
Study 15137919 — intervention group
Group type: COMPARATOR
Intervention: Rest (control group)
Number of subjects: 11
Study 15137919 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 11
Study 15137919 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 11
Study 11320027 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser photorefractive keratectomy
Number of subjects: 75
Study 9631990 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg
Number of subjects: 349
Study 9631990 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 300 mg
Number of subjects: 349
Study 9631990 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg
Number of subjects: 349
Study 9631990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349
Study 8142528 — intervention group
Group type: EXPERIMENTAL
Intervention: Leprosy patients living outside leprosaria
Number of subjects: 51
Study 8142528 — intervention group
Group type: EXPERIMENTAL
Intervention: Leprosy patients living inside leprosaria
Number of subjects: 51
Study 8142528 — intervention group
Group type: COMPARATOR
Intervention: Leprosy patients compared to controls
Number of subjects: 51
Study 8142528 — intervention group
Group type: COMPARATOR
Intervention: Leprosy patients and controls regarding HIV tests
Number of subjects: 51
Study 2892437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 50 micrograms/kg, Pancuronium 100 micrograms/kg (Group FP)
Number of subjects: 101
Study 2892437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 50 micrograms/kg, Vecuronium 80 micrograms/kg (Group FV)
Number of subjects: 101
Study 2892437 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms/kg, Pancuronium 100 micrograms/kg (Group SP)
Number of subjects: 101
Study 2892437 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms/kg, Vecuronium 80 micrograms/kg (Group SV)
Number of subjects: 101
Study 31562908 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral TAVR in women
Number of subjects: 12381
Study 31562908 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral TAVR in men
Number of subjects: 12381
Study 31562908 — intervention group
Group type: COMPARATOR
Intervention: Temporal changes in outcomes for men
Number of subjects: 12381
Study 31562908 — intervention group
Group type: COMPARATOR
Intervention: Temporal changes in outcomes for women
Number of subjects: 12381
Study 29178891 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Haemodialysis Care (SHC)
Number of subjects: 600
Study 26902035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidized Regenerated Cellulose (ORC)
Number of subjects: 40
Study 26902035 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 23182622 — intervention group
Group type: EXPERIMENTAL
Intervention: Social deception condition
Number of subjects: 55
Study 23182622 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 55
Study 21233311 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 192
Study 21233311 — intervention group
Group type: COMPARATOR
Intervention: ATG/CSA
Number of subjects: 192
Study 18400730 — intervention group
Group type: COMPARATOR
Intervention: Sunflower-oil capsules (3 g/d; control)
Number of subjects: 276
Study 18400730 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod (3 x 150 g/wk)
Number of subjects: 276
Study 18400730 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon (3 x 150 g/wk)
Number of subjects: 276
Study 18400730 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-oil capsules (3 g/d)
Number of subjects: 276
Study 17038942 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII (rFVIIa) at doses of 40, 80, or 160 mug/kg
Number of subjects: 374
Study 17038942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study 17038942 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII (rFVIIa)
Number of subjects: 374
Study 12655421 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily inhalation plus daily hydrotherapy
Number of subjects: 146
Study 12655421 — intervention group
Group type: COMPARATOR
Intervention: Daily inhalation of normal saline (control)
Number of subjects: 146
Study 11250737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical models for predicting metastatic growth initiation
Number of subjects: 0
Study 11250737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical models for evaluating operative therapy
Number of subjects: 0
Study 11250737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical models for chemotherapy administration
Number of subjects: 0
Study 9108699 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased use of words associated with insightful and causal thinking
Number of subjects: 177
Study 9108699 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher use of positive relative to negative emotion words
Number of subjects: 177
Study 9108699 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical measure derived from data
Number of subjects: 177
Study 9108699 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive change and empirical models
Number of subjects: 177
Study 1439943 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% clindamycin vaginal cream (5 g applied intravaginally at bedtime for 7 days) with placebo oral tablets twice daily for 7 days
Number of subjects: 60
Study 1439943 — intervention group
Group type: COMPARATOR
Intervention: Oral metronidazole tablets (500 mg twice a day for 7 days) with placebo vaginal cream (5 g intravaginally for 7 days)
Number of subjects: 60
Study 3158243 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 0.15 mg/kg
Number of subjects: 47
Study 3158243 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg
Number of subjects: 47
Study 3158243 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubocurarine 0.05 mg/kg
Number of subjects: 47
Study 3158243 — intervention group
Group type: COMPARATOR
Intervention: Suxamethonium 1 mg/kg
Number of subjects: 47
Study 31910050 — intervention group
Group type: EXPERIMENTAL
Intervention: Full package (all strategies)
Number of subjects: 1276
Study 31910050 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment call
Number of subjects: 1276
Study 31910050 — intervention group
Group type: COMPARATOR
Intervention: Engagement‐as‐usual (EAU)
Number of subjects: 1276
Study 28440898 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 1845
Study 28440898 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter
Number of subjects: 1845
Study 28440898 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter (outpatient setting)
Number of subjects: 1845
Study 27978857 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention programme for CVRM
Number of subjects: 34
Study 27978857 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 27978857 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 34
Study 24879550 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl chloride spray
Number of subjects: 60
Study 24879550 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 60
Study 22769423 — intervention group
Group type: EXPERIMENTAL
Intervention: Human acellular dermal matrix (ADM) implantation following total parotidectomy
Number of subjects: 70
Study 22769423 — intervention group
Group type: COMPARATOR
Intervention: Control group (total parotidectomy without ADM)
Number of subjects: 70
Study 20819427 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic surgery (HALS)
Number of subjects: 0
Study 20819427 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study 19052241 — intervention group
Group type: EXPERIMENTAL
Intervention: Home rehabilitation
Number of subjects: 102
Study 19052241 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 102
Study 16005362 — intervention group
Group type: EXPERIMENTAL
Intervention: Goshajinkigan (GJG) 7.5 g/day for 1 month
Number of subjects: 71
Study 16005362 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GJG treatment)
Number of subjects: 71
Study 12974591 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP (Group PEEP, n = 28)
Number of subjects: 50
Study 12974591 — intervention group
Group type: COMPARATOR
Intervention: Zero PEEP (Group ZEEP, n = 22)
Number of subjects: 50
Study 10710846 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient contribution to the therapeutic alliance and perceived quality of the therapeutic relationship
Number of subjects: 0
Study 10710846 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfectionism
Number of subjects: 0
Study 10710846 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance
Number of subjects: 0
Study 9358963 — intervention group
Group type: EXPERIMENTAL
Intervention: nisoldipine CC
Number of subjects: 278
Study 9358963 — intervention group
Group type: COMPARATOR
Intervention: lisinopril
Number of subjects: 278
Study 9358963 — intervention group
Group type: EXPERIMENTAL
Intervention: combination therapy (nisoldipine CC and lisinopril)
Number of subjects: 278
Study 1389940 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg zidovudine after a 25 g protein meal
Number of subjects: 11
Study 1389940 — intervention group
Group type: COMPARATOR
Intervention: 200 mg zidovudine in a fasting state
Number of subjects: 11
Study 3930309 — intervention group
Group type: EXPERIMENTAL
Intervention: Miraxid (pivmecillinam 200 mg plus pivampicillin 250 mg)
Number of subjects: 408
Study 3930309 — intervention group
Group type: COMPARATOR
Intervention: Deteclo (tetracycline hydrochloride, chlortetracycline hydrochloride, and demeclocycline hydrochloride 300 mg)
Number of subjects: 408
Study 3930309 — intervention group
Group type: EXPERIMENTAL
Intervention: Miraxid
Number of subjects: 408
Study 3930309 — intervention group
Group type: COMPARATOR
Intervention: Deteclo
Number of subjects: 408
Study 30368034 — intervention group
Group type: EXPERIMENTAL
Intervention: Review of patient and family feedback (PFF) with a faculty coach
Number of subjects: 114
Study 30368034 — intervention group
Group type: COMPARATOR
Intervention: Independent review of patient and family feedback (PFF)
Number of subjects: 114
Study 29180073 — intervention group
Group type: EXPERIMENTAL
Intervention: Front-of-pack nutritional rating information
Number of subjects: 0
Study 29180073 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nutritional rating information)
Number of subjects: 0
Study 27348923 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical stone needle on foot combined with bian anvil at Yintang (CV 29), applied at Yongquan (KI 1), Taichong (LR 3), and Gongsun (SP 4) for 2 weeks, once a day with 2 days rest between treatments.
Number of subjects: 70
Study 27348923 — intervention group
Group type: COMPARATOR
Intervention: Common acupuncture at Sanyinjiao (SP 6), Shenmen (HT 7), and Sishencong (EX-HN 1) for 2 weeks, once a day with 2 days rest between treatments.
Number of subjects: 70
Study 27348923 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups were followed up after treatment.
Number of subjects: 70
Study 24682079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral thoracic paravertebral block with 0.25% ropivacaine 0.5 mL/kg and 1:200,000 epinephrine
Number of subjects: 30
Study 24682079 — intervention group
Group type: COMPARATOR
Intervention: Control group (intravenous PCA)
Number of subjects: 30
Study 23006443 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (Bisocard® 10 mg)
Number of subjects: 26
Study 23006443 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (Concor 10®)
Number of subjects: 26
Study 23006443 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 26
Study 20617193 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-only intervention
Number of subjects: 1000
Study 20617193 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual intervention
Number of subjects: 1000
Study 20617193 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual intervention with HAART included
Number of subjects: 1000
Study 20617193 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1000
Study 17629805 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT) with dosage 1.5 J/per point, applied once a day for 10 days.
Number of subjects: 19
Study 17629805 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser therapy (control group).
Number of subjects: 19
Study 11764012 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 30
Study 11764012 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg triazolam
Number of subjects: 30
Study 11764012 — intervention group
Group type: COMPARATOR
Intervention: 0 mg (placebo)
Number of subjects: 30
Study 9432092 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal graded treadmill test (VO2max = 30.3 +/- 5.7 mL x min‐1 x kg‐1)
Number of subjects: 17
Study 9432092 — intervention group
Group type: COMPARATOR
Intervention: 30-min control rest periods
Number of subjects: 17
Study 7685452 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg sublingually)
Number of subjects: 20
Study 7685452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7685452 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine (8 micrograms/kg/min)
Number of subjects: 20
Study 3103412 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent transdermal nitroglycerin (16 hours/day)
Number of subjects: 10
Study 3103412 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal nitroglycerin (24 hours/day)
Number of subjects: 10
Study 3103412 — intervention group
Group type: COMPARATOR
Intervention: Control value (before treatment)
Number of subjects: 10
Study 29764793 — intervention group
Group type: EXPERIMENTAL
Intervention: Hashimoto’s thyroiditis (HT) group
Number of subjects: 60
Study 29764793 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 60
Study 26801358 — intervention group
Group type: EXPERIMENTAL
Intervention: Interposed Abdominal Compression CPR (IAC-CPR)
Number of subjects: 80
Study 26801358 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR (STD-CPR)
Number of subjects: 80
Study 25867538 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg dose intravenously)
Number of subjects: 181
Study 25867538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 23221367 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic spine thrust manipulation combined with cervical spine nonthrust manipulation
Number of subjects: 64
Study 23221367 — intervention group
Group type: COMPARATOR
Intervention: Cervical spine nonthrust manipulation alone
Number of subjects: 64
Study 20501353 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine infiltration
Number of subjects: 40
Study 20501353 — intervention group
Group type: COMPARATOR
Intervention: Saline infiltration
Number of subjects: 40
Study 18004060 — intervention group
Group type: EXPERIMENTAL
Intervention: Local thrombolysis
Number of subjects: 0
Study 18004060 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 0
Study 18004060 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional neuroradiology
Number of subjects: 0
Study 18004060 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study 16911320 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced priming (RP) system for CPB
Number of subjects: 11
Study 12815913 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE), 0.625 mg/d, and medroxyprogesterone acetate (MPA), 5 mg/d
Number of subjects: 50
Study 12815913 — intervention group
Group type: COMPARATOR
Intervention: Tibolone, 2.5 mg/d
Number of subjects: 50
Study 10901494 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE exercise counseling
Number of subjects: 812
Study 10901494 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 812
Study 8774205 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol, 2 mg/d for the first 6 months
Number of subjects: 100
Study 8774205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 1465288 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) with metoclopramide (MCP) 1.5 mg/kg (group B)
Number of subjects: 172
Study 1465288 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) with metoclopramide (MCP) 2 mg/kg (group D)
Number of subjects: 172
Study 1465288 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (MCP) 1.5 mg/kg (group A)
Number of subjects: 172
Study 1465288 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (MCP) 2 mg/kg (group C)
Number of subjects: 172
Study 30952920 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming eye mask
Number of subjects: 19
Study 30952920 — intervention group
Group type: COMPARATOR
Intervention: Sham eye mask
Number of subjects: 19
Study 25748642 — intervention group
Group type: COMPARATOR
Intervention: Apraclonidine hydrochloride 0.5% (APRA)
Number of subjects: 97
Study 25748642 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of brinzolamide 1% and timolol 0.5% (FCBT)
Number of subjects: 97
Study 25022107 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint injection combined with plum-blossom needle
Number of subjects: 48
Study 25022107 — intervention group
Group type: COMPARATOR
Intervention: Western medication (control group)
Number of subjects: 48
Study 23158895 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 40
Study 23158895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40